Zobrazeno 1 - 10
of 26
pro vyhledávání: '"T. J. A. Van Nijnatten"'
Autor:
L. M. F. H. Neeter, I. P. L. Houben, P. J. Nelemans, T. J. A. Van Nijnatten, R. M. Pijnappel, C. Frotscher, M. Osinga-de Jong, F. Sanders, T. Van Dalen, H. P. J. Raat, B. A. B. Essers, J. E. Wildberger, M. L. Smidt, M. B. I. Lobbes
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-10 (2019)
Abstract Background In the Dutch breast cancer screening program, women recalled with a BI-RADS 0 score are referred for additional imaging, while those with BI-RADS 4/5 scores are also directed to an outpatient breast clinic. Approximately six out o
Externí odkaz:
https://doaj.org/article/3ba9aef3c8de49ab881f1b44c48f8395
Autor:
T. J. A. van Nijnatten, Kristien Keymeulen, Marjolein L. Smidt, Sabine Siesling, Loes F. S. Kooreman, R.A.W. Ploumen, S.M.J. van Kuijk
Publikováno v:
European Journal of Surgical Oncology, 48(1), 60-66. ELSEVIER SCI LTD
European journal of surgical oncology, 48(1), 60-66. Elsevier
European journal of surgical oncology, 48(1), 60-66. Elsevier
INTRODUCTION: Neoadjuvant systemic therapy (NST) is increasingly applied in breast cancer to improve surgical and oncological outcome. Approximately 21% of patients receiving NST achieve pathological complete response (pCR) of the breast. There is di
Autor:
C M, de Mooij, S, Samiei, C, Mitea, M B I, Lobbes, L F S, Kooreman, E M, Heuts, R G H, Beets-Tan, T J A, van Nijnatten, M L, Smidt
Publikováno v:
Clinical radiology. 77(10)
To investigate the diagnostic performance of dedicated axillary hybridTen prospectively included clinically node-positive breast cancer patients underwent dedicated axillary hybridSix patients achieved axillary pCR at final histopathology. A total of
Autor:
B. Goorts, Esther M. Heuts, M. Moossdorff, MC van Maaren, M. Vane, T. J. A. van Nijnatten, Luc J. A. Strobbe, Marjolein L. Smidt
Publikováno v:
Breast Cancer Research and Treatment
Breast cancer research and treatment, 186(3), 863-870. Springer
Breast Cancer Research and Treatment, 186(3), 863-870. Springer, Cham
Breast cancer research and treatment, 186(3), 863-870. Springer
Breast Cancer Research and Treatment, 186(3), 863-870. Springer, Cham
Background After breast cancer treatment, follow-up consists of physical examination and mammography for at least 5 years, to detect local and regional recurrence. The risk of recurrence may decrease after event-free time. This study aims to determin
Autor:
C. C. van der Pol, Ernest J. T. Luiten, L.B. Koppert, Marjut Leidenius, Petra G. Boelens, C.J.H. van de Velde, A. J. G. Maaskant-Braat, T. J. A. van Nijnatten, J. M. Simons, Marjolein L. Smidt, Riccardo A. Audisio
Publikováno v:
European Journal of Surgical Oncology, 46(1), 53-58. W.B. Saunders
European Journal of Surgical Oncology, 46(1), 53-58. ELSEVIER SCI LTD
European Journal of Surgical Oncology, 46(1), 53-58. ELSEVIER SCI LTD
Introduction: Various options for axillary staging after neoadjuvant systemic therapy (NST) are available for breast cancer patients with a clinically positive axillary node (cN+). This survey assessed current practices amongst breast cancer speciali
Autor:
Marc B. I. Lobbes, Sanne M. E. Engelen, S. M. J. van Kuijk, Renée W Y Granzier, Sabine Siesling, Marjolein L. Smidt, R. R. J. W. van der Hulst, Liesbeth J. Boersma, Sanaz Samiei, L. de Munck, B. N. van Kaathoven, T. J. A. van Nijnatten
Publikováno v:
Annals of Surgical Oncology
Annals of Surgical Oncology, 26(12), 3902-3909. Springer, Cham
Annals of surgical oncology, 26(12), 3902-3909. Springer
Annals of Surgical Oncology, 26(12), 3902-3909. Springer, Cham
Annals of surgical oncology, 26(12), 3902-3909. Springer
Background. Residual axillary lymph node involvement after neoadjuvant systemic therapy (NST) is the determining factor for postmastectomy radiation therapy (PMRT). Preoperative identification of patients needing PMRT is essential to enable shared de
Autor:
Marc B. I. Lobbes, Loes F. S. Kooreman, L.M. van Roozendaal, Patty J. Nelemans, Robert-Jan Schipper, Marjolein L. Smidt, M. Vane, T. J. A. van Nijnatten, Kristien Keymeulen
Publikováno v:
European Journal of Surgical Oncology, 45(4), 573-577. ELSEVIER SCI LTD
Introduction: Imaging findings can be affected by histopathological characteristics, such as breast cancer subtypes. The aim was to determine whether the diagnostic performance, in particular negative predictive value (NPV), of axillary US differs pe
Autor:
Marc B. I. Lobbes, T. J. A. van Nijnatten, L. P. T. van Tiel, Catharina G.M. Groothuis-Oudshoorn, Sabine Siesling, Adri C. Voogd
Publikováno v:
Breast Cancer Research and Treatment, 184(3), 951-963. Springer, Cham
Breast cancer research and treatment, 184(3), 951-963. Springer
Breast Cancer Research and Treatment
Breast cancer research and treatment, 184(3), 951-963. Springer
Breast Cancer Research and Treatment
Purpose To evaluate the effect of breast MRI on overall survival (OS) and disease-free survival (DFS) of patients with invasive breast cancer in the Netherlands. Methods We selected all women from the Netherlands Cancer Registry diagnosed with invasi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58d3f69f8b4f658a676e705479de3558
https://cris.maastrichtuniversity.nl/en/publications/c056ccd9-6c20-447a-afc5-82c698384845
https://cris.maastrichtuniversity.nl/en/publications/c056ccd9-6c20-447a-afc5-82c698384845
Autor:
F. B. M. Sanders, L. M. F. H. Neeter, Ruud M. Pijnappel, T. J. A. van Nijnatten, I. P. L. Houben, Marjolein L. Smidt, Marc B. I. Lobbes, Brigitte A. B. Essers, Patty J. Nelemans, M. Osinga-de Jong, T. van Dalen, Joachim E. Wildberger, C. Frotscher, H.P.J. (Frank) Raat
Publikováno v:
Trials, 20(1):759. BioMed Central Ltd
Trials
Trials, 20(1). BioMed Central
Trials, Vol 20, Iss 1, Pp 1-10 (2019)
Trials
Trials, 20(1). BioMed Central
Trials, Vol 20, Iss 1, Pp 1-10 (2019)
Background In the Dutch breast cancer screening program, women recalled with a BI-RADS 0 score are referred for additional imaging, while those with BI-RADS 4/5 scores are also directed to an outpatient breast clinic. Approximately six out of ten wom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36307b14e8ec96f05a59f497966d3f92
https://cris.maastrichtuniversity.nl/en/publications/742ab1db-3baf-4154-bad4-f72433af70f4
https://cris.maastrichtuniversity.nl/en/publications/742ab1db-3baf-4154-bad4-f72433af70f4
Autor:
Ernest J. T. Luiten, Linetta B. Koppert, J. M. Simons, Kelly K. Hunt, C. C. van der Pol, A W K S Marinelli, T. J. A. van Nijnatten, L M Pereira Arias-Bouda, Marjolein L. Smidt, A M Zeillemaker, M L M A van Pelt, M E Straver
Publikováno v:
British Journal of Surgery, 106(12), 1632-1639. Wiley
British Journal of Surgery, 106(12), 1632-1639. John Wiley & Sons Ltd.
British Journal of Surgery, 106(12), 1632-1639. WILEY
British Journal of Surgery, 106(12), 1632. John Wiley and Sons Ltd
The British Journal of Surgery
British Journal of Surgery, 106(12), 1632-1639. John Wiley & Sons Ltd.
British Journal of Surgery, 106(12), 1632-1639. WILEY
British Journal of Surgery, 106(12), 1632. John Wiley and Sons Ltd
The British Journal of Surgery
Background Marking the axilla with radioactive iodine seed and sentinel lymph node (SLN) biopsy have been proposed for axillary staging after neoadjuvant systemic therapy in clinically node‐positive breast cancer. This study evaluated the identific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f2f71a756e5de2774a7d604a4225506
https://cris.maastrichtuniversity.nl/en/publications/14ba691c-ab4e-4c51-b017-b8d4bb082517
https://cris.maastrichtuniversity.nl/en/publications/14ba691c-ab4e-4c51-b017-b8d4bb082517